PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells

By          

International Journal of Oncology, Vol. 42, Iss. 2, 2013-01 ,pp. : 419-428

Spandidos Publications

Access to resources Recommend Favorite

Life and Death of Leukemic Cells Under Bcr-Abl Signaling Control

By  

Current Cancer Therapy Reviews, Vol. 5, Iss. 4, 2009-11 ,pp. : 303-309

Bentham Science Publishers

Access to resources Recommend Favorite

A novel tricolor, dual-fusion fluorescence in situ hybridization method to detect BCR/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemia

By Smoley S.A.   Brockman S.R.   Paternoster S.F.   Meyer R.G.   Dewald G.W.  

Cancer Genetics and Cytogenetics, Vol. 148, Iss. 1, 2004-01 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite

RNA interference-mediated knockdown of Livin suppresses cell proliferation and invasion and enhances the chemosensitivity to cisplatin in human osteosarcoma cells

By              

International Journal of Oncology, Vol. 43, Iss. 1, 2013-01 ,pp. : 159-168

Spandidos Publications

Access to resources Recommend Favorite

Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1-BCR-ABL-JAK2 Complex

By Chen Min   Gallipoli Paolo   DeGeer Donna   Sloma Ivan   Forrest Donna L.   Chan Matthew   Lai Damian   Jorgensen Heather   Ringrose Ashley   Wang Hui Mi   Lambie Karen   Nakamoto Helen   Saw Kyi Min   Turhan Ali   Arlinghaus Ralph   Paul James   Stobo Jon   Barnett Michael J.   Eaves Allen   Eaves Connie J   Holyoake Tessa L.   Jiang Xiaoyan  

Journal of the National Cancer Institute, Vol. 105, Iss. 6, 2013-03 ,pp. : 405-423

Oxford University Press

Access to resources Recommend Favorite